BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines

• Published in: npj vaccines 2020-03, Vol.5 (1), p.21-21, Article 21
• Main Authors: Segura-Cerda, Cristian Alfredo, Marquina-Castillo, Brenda, Lozano-Ordaz, Vasti, Mata-Espinosa, Dulce, Barrios-Payán, Jorge Alberto, López-Torres, Manuel O., Aceves-Sánchez, Michel de Jesús, Bielefeldt-Ohmann, Helle, Hernández-Pando, Rogelio, Flores-Valdez, Mario Alberto
• Format: Article
• Language: English
• Subjects: 631/250/590; 631/250/590/1867; Biomedical and Life Sciences; Biomedicine; Cytokines; Dendritic cells; Diabetes; Immune response; Immunization; Infections; Infectious Diseases; Lymphocytes; Medical Microbiology; Pneumonia; Public Health; Tuberculosis; Vaccine; Vaccines; Virology
• ISSN: 2059-0105; 2059-0105
• DOI: 10.1038/s41541-020-0169-6

Comorbidity between Tuberculosis (TB) and type 2 diabetes (T2D) is one of the greatest contributors to the spread of Mycobacterium tuberculosis (M. tuberculosis) in low- and middle-income countries. T2D compromises key steps of immune responses against M. tuberculosis and it might affect the protection afforded by vaccine candidates against TB. We compared the protection and immune response afforded by the BCGΔBCG1419c vaccine candidate versus that of wild-type BCG in mice with T2D. Vaccination with both BCGΔBCG1419c, BCG or infection with M. tuberculosis reduced weight loss, hyperglycemia, and insulin resistance during T2D progression, suggesting that metabolic changes affecting these parameters were affected by mycobacteria. For control of acute TB, and compared with non-vaccinated controls, BCG showed a dominant T CD4 + response whereas BCGΔBCG1419c showed a dominant T CD8 + /B lymphocyte response. Moreover, BCG maintained an increased response in lung cells via IFN-γ, TNF-α, and IL-4, while BCGΔBCG1419c increased IFN-γ but reduced IL-4 production. As for chronic TB, and compared with non-vaccinated controls, both BCG strains had a predominant presence of T CD4 + lymphocytes. In counterpart, BCGΔBCG1419c led to increased presence of dendritic cells and an increased production of IL-1 β. Overall, while BCG effectively reduced pneumonia in acute infection, it failed to reduce it in chronic infection, whereas we hypothesize that increased production of IL-1 β induced by BCGΔBCG1419c contributed to reduced pneumonia and alveolitis in chronic TB. Our results show that BCG and BCGΔBCG1419c protect T2D mice against TB via different participation of T and B lymphocytes, dendritic cells, and pro-inflammatory cytokines.